Annual Total Liabilities
$6.14 M
-$1.48 M-19.39%
December 31, 2023
Summary
- As of February 12, 2025, SBFM annual total liabilities is $6.14 million, with the most recent change of -$1.48 million (-19.39%) on December 31, 2023.
- During the last 3 years, SBFM annual total liabilities has risen by +$4.14 million (+206.93%).
- SBFM annual total liabilities is now -99.99% below its all-time high of $93.64 billion, reached on December 1, 2003.
Performance
SBFM Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$5.02 M
-$793.60 K-13.66%
September 30, 2024
Summary
- As of February 12, 2025, SBFM quarterly total liabilities is $5.02 million, with the most recent change of -$793.60 thousand (-13.66%) on September 30, 2024.
- Over the past year, SBFM quarterly total liabilities has dropped by -$669.30 thousand (-11.77%).
- SBFM quarterly total liabilities is now -34.12% below its all-time high of $7.62 million, reached on December 31, 2022.
Performance
SBFM Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
SBFM Total Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -19.4% | -11.8% |
3 y3 years | +206.9% | -5.3% |
5 y5 years | +410.6% | -5.3% |
SBFM Total Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -19.4% | +208.3% | -34.1% | +5170.5% |
5 y | 5-year | -19.4% | +636.6% | -34.1% | +5170.5% |
alltime | all time | -100.0% | >+9999.0% | -34.1% | -100.0% |
Sunshine Biopharma Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $5.02 M(-13.7%) |
Jun 2024 | - | $5.81 M(-17.9%) |
Mar 2024 | - | $7.08 M(+15.3%) |
Dec 2023 | $6.14 M(-19.4%) | $6.14 M(+8.0%) |
Sep 2023 | - | $5.69 M(+7.3%) |
Jun 2023 | - | $5.30 M(-29.9%) |
Mar 2023 | - | $7.56 M(-0.7%) |
Dec 2022 | $7.62 M(+282.5%) | $7.62 M(+1486.1%) |
Sep 2022 | - | $480.20 K(+358.6%) |
Jun 2022 | - | $104.70 K(+10.0%) |
Mar 2022 | - | $95.20 K(-95.2%) |
Dec 2021 | $1.99 M(-0.5%) | - |
Dec 2021 | - | $1.99 M(-45.8%) |
Sep 2021 | - | $3.68 M(+36.7%) |
Jun 2021 | - | $2.69 M(-8.6%) |
Mar 2021 | - | $2.94 M(+47.1%) |
Dec 2020 | $2.00 M(+140.0%) | $2.00 M(+81.0%) |
Sep 2020 | - | $1.11 M(+47.5%) |
Jun 2020 | - | $749.40 K(-3.0%) |
Mar 2020 | - | $772.30 K(-7.3%) |
Dec 2019 | $833.50 K(-30.7%) | $833.50 K(-6.3%) |
Sep 2019 | - | $889.20 K(-3.9%) |
Jun 2019 | - | $925.70 K(-36.5%) |
Mar 2019 | - | $1.46 M(+21.3%) |
Dec 2018 | $1.20 M(+44.7%) | $1.20 M(+13.5%) |
Sep 2018 | - | $1.06 M(-26.7%) |
Jun 2018 | - | $1.45 M(-3.8%) |
Mar 2018 | - | $1.50 M(+80.9%) |
Dec 2017 | $830.80 K(+203.1%) | $830.80 K(+36.2%) |
Sep 2017 | - | $609.90 K(-21.9%) |
Jun 2017 | - | $780.60 K(+174.4%) |
Mar 2017 | - | $284.50 K(+3.8%) |
Dec 2016 | $274.10 K(-78.4%) | $274.10 K(-0.9%) |
Sep 2016 | - | $276.70 K(-77.2%) |
Jun 2016 | - | $1.21 M(+2.3%) |
Mar 2016 | - | $1.19 M(-6.6%) |
Dec 2015 | $1.27 M | $1.27 M(+170.5%) |
Sep 2015 | - | $469.60 K(+7.7%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2015 | - | $436.10 K(+15.0%) |
Mar 2015 | - | $379.20 K(-28.6%) |
Dec 2014 | $531.00 K(+1265.0%) | $531.00 K(+16.3%) |
Sep 2014 | - | $456.60 K(+19.4%) |
Jun 2014 | - | $382.30 K(+106.6%) |
Mar 2014 | - | $185.00 K(+375.6%) |
Dec 2013 | $38.90 K(-39.6%) | $38.90 K(+65.5%) |
Sep 2013 | - | $23.50 K(+59.9%) |
Jun 2013 | - | $14.70 K(-34.4%) |
Mar 2013 | - | $22.40 K(-65.2%) |
Dec 2012 | $64.40 K(+1794.1%) | $64.40 K(+332.2%) |
Sep 2012 | - | $14.90 K(-49.3%) |
Jun 2012 | - | $29.40 K(+43.4%) |
Mar 2012 | - | $20.50 K(+502.9%) |
Dec 2011 | $3400.00(-70.2%) | $3400.00(-24.4%) |
Sep 2011 | - | $4500.00(>+9900.0%) |
Jun 2011 | - | $0.00(-100.0%) |
Mar 2011 | - | $300.00(-97.4%) |
Dec 2010 | $11.40 K(-20.3%) | $11.40 K(-52.1%) |
Sep 2010 | - | $23.80 K(+42.5%) |
Jun 2010 | - | $16.70 K(+4.4%) |
Mar 2010 | - | $16.00 K(>+9900.0%) |
Dec 2009 | $14.30 K(-67.1%) | - |
Oct 2009 | - | $0.00(-100.0%) |
Jul 2009 | $43.40 K(+91.2%) | $43.40 K(+25.4%) |
Apr 2009 | - | $34.60 K(+18.1%) |
Jan 2009 | - | $29.30 K(+9.7%) |
Oct 2008 | - | $26.70 K(+17.6%) |
Jul 2008 | $22.70 K(+1413.3%) | $22.70 K(+30.5%) |
Apr 2008 | - | $17.40 K(+596.0%) |
Jan 2008 | - | $2500.00(-24.2%) |
Oct 2007 | - | $3300.00 |
Jul 2007 | $1500.00(-100.0%) | - |
Dec 2003 | $93.64 B(+9.1%) | - |
Dec 2002 | $85.85 B(+77.3%) | - |
Dec 2001 | $48.43 B(-18.8%) | - |
Dec 2000 | $59.65 B(+8.7%) | - |
Dec 1999 | $54.87 B(+4.7%) | - |
Dec 1998 | $52.41 B | - |
FAQ
- What is Sunshine Biopharma annual total liabilities?
- What is the all time high annual total liabilities for Sunshine Biopharma?
- What is Sunshine Biopharma annual total liabilities year-on-year change?
- What is Sunshine Biopharma quarterly total liabilities?
- What is the all time high quarterly total liabilities for Sunshine Biopharma?
- What is Sunshine Biopharma quarterly total liabilities year-on-year change?
What is Sunshine Biopharma annual total liabilities?
The current annual total liabilities of SBFM is $6.14 M
What is the all time high annual total liabilities for Sunshine Biopharma?
Sunshine Biopharma all-time high annual total liabilities is $93.64 B
What is Sunshine Biopharma annual total liabilities year-on-year change?
Over the past year, SBFM annual total liabilities has changed by -$1.48 M (-19.39%)
What is Sunshine Biopharma quarterly total liabilities?
The current quarterly total liabilities of SBFM is $5.02 M
What is the all time high quarterly total liabilities for Sunshine Biopharma?
Sunshine Biopharma all-time high quarterly total liabilities is $7.62 M
What is Sunshine Biopharma quarterly total liabilities year-on-year change?
Over the past year, SBFM quarterly total liabilities has changed by -$669.30 K (-11.77%)